It's actually you that hasn't bothered to read anything. Race is doing a P2 trial in mainly breast ca with other cancers that respond. This has nothing to do with AML and your agenda, as we're talking specifically about CPAC.
again efficacy>cost in treatment profile. I've read what youve written too bad I can't say the same for you.
and even if they are in the same lines, if it turns out more efficacious, I'm sure itll still be used over cheaper treatments with a poorer prognostic profile.
By your absurd logic, everyone should be on chemo treatment cos it costs significantly less than precision oncology. I'll tell they payers RIGHT NOW that BGN things keytruda is far too expensive compared to dox treatment so they shouldnt pay it LOL.
Cardioprotection thread, page-698
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.83 |
Change
-0.030(1.61%) |
Mkt cap ! $311.7M | |||
| Open | High | Low | Value | Volume |
| $1.86 | $1.91 | $1.79 | $169.3K | 92.02K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 92 | $1.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.87 | 3472 | 1 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |